Simple and reliable factor V genotyping by PNA-mediated PCR clamping

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Activated protein C (APC) resistance is a primary genetic risk factor for thrombophilia.
• This resistance is predominantly caused by a specific point mutation (G1691A) in the factor V gene, known as Factor V Leiden.
• Existing molecular diagnostic methods include PCR-RFLP, PCR-SSP, and OLA.

Purpose of the Study:

• To introduce and evaluate a novel peptide nucleic acid (PNA)-mediated PCR clamping assay for Factor V Leiden genotyping.
• To assess the sensitivity and specificity of the PNA-based method for discriminating between different Factor V genotypes.
• To compare the performance of the PNA assay against a conventional PCR-RFLP technique.

Main Methods:

• Development of a PNA-mediated PCR clamping assay utilizing allele-specific PNAs.
• Application of the PNA assay to genotype DNA samples from 60 patients with suspected venous thrombosis.
• Comparative analysis with the established PCR-RFLP method for validation.

Main Results:

• The PNA-mediated PCR clamping method demonstrated high sensitivity to base pair mismatches, enabling clear discrimination of Factor V Leiden allelic status (heterozygous, homozygous normal, homozygous mutant).
• The PNA assay achieved 100% concordance with the conventional PCR-RFLP technique in the prospective study.
• No additional confirmation steps were required with the PNA-based genotyping.

Conclusions:

• PNA-mediated PCR clamping is a highly sensitive and accurate method for Factor V Leiden genotyping.
• This novel approach eliminates the need for post-PCR analysis or confirmation steps.
• The PNA assay is suitable for large-scale screening of individuals at risk for deep venous thrombosis.